Innovation Pharmaceuticals Inc. (OTCMKTS:IPIX) Short Interest Up 9.6% in August

Innovation Pharmaceuticals Inc. (OTCMKTS:IPIXGet Free Report) was the recipient of a significant increase in short interest in the month of August. As of August 31st, there was short interest totalling 511,100 shares, an increase of 9.6% from the August 15th total of 466,200 shares. Based on an average daily volume of 948,300 shares, the days-to-cover ratio is currently 0.5 days.

Innovation Pharmaceuticals Stock Performance

IPIX stock traded down $0.00 during mid-day trading on Tuesday, reaching $0.02. The company had a trading volume of 78,738 shares, compared to its average volume of 375,206. Innovation Pharmaceuticals has a one year low of $0.01 and a one year high of $0.04. The stock’s 50-day simple moving average is $0.02 and its two-hundred day simple moving average is $0.02.

About Innovation Pharmaceuticals

(Get Free Report)

Innovation Pharmaceuticals Inc, a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective. The company's lead drug candidate is Brilacidin, a therapeutic for the treatment of oral mucositis, inflammatory bowel disease, acute bacterial skin and skin structure infection, and COVID-19.

Further Reading

Receive News & Ratings for Innovation Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovation Pharmaceuticals and related companies with's FREE daily email newsletter.